Joseph C. Cappelleri earned his MS in statistics from the City University of New York (Baruch College), PhD in psychometrics from Cornell University, and MPH in epidemiology from Harvard University. Dr. Cappelleri is an executive director of biostatistics in the Statistical Research and Data Science Center at Pfizer Inc, where he is the recipient of the Craig A. Saxton Clinical Development Excellence Award. As an adjunct professor, he has served on the faculties at Brown University (biostatistics), Tufts Medical Center (medicine), and the University of Connecticut (statistics). Among the most published authors and most prolific medical researchers in the history of Pfizer and the pharmaceutical industry, Dr. Cappelleri has co-authored hundreds and hundreds of publications (and external presentations) on clinical and methodological topics, including regression-discontinuity designs, meta-analysis, and health measurement scales. He is the lead author of the book "Patient-Reported Outcomes: Measurement, Implementation and Interpretation" and has co-authored or co-edited five other books ("Statistical Topics in Health Economics and Outcomes Research," "Phase II Clinical Development of New Drugs," "Design and Analysis of Subgroups with Biopharmaceutical Applications," "A Practical Approach to Quantitative Validation of Patient-Reported Outcomes: A Simulation-based Guide Using SAS," and "Dose Finding and Beyond in Biopharmaceutical Development"). Dr. Cappelleri is an elected Fellow of the American Statistical Association (ASA), an elected recipient of the Long-Term Excellence Award from the Health Policy Statistics Section of the ASA, and an elected recipient of the ISPOR Avedis Donabedian Outcomes Research Lifetime Achievement Award.
